CAS: 1675248-19-7
Tofacitinib Amide (3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanamide)
CAS:1675248-19-7
Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, …
Formula:
C16H22N6O2
Color and Shape:
White Off-White Solid
Molecular weight:
330.18042
Estimated delivery in United States, on Thursday 2 May 2024
3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide
CAS:1675248-19-7
Formula:
C16H22N6O2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
330.3849
Ref: AN-AG00ABHG
100mg | 12,883.00 € |
Estimated delivery in United States, on Friday 3 May 2024
Tofacitinib Impurity 61
CAS:1675248-19-7
Formula:
C16H22N6O2
Color and Shape:
White To Off-White Solid
Molecular weight:
330.39
Ref: 4Z-T-117025
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Estimated delivery in United States, on Monday 6 May 2024
Tofacitinib impurity L
CAS:1675248-19-7
Impurity Tofacitinib Impurity (T528000) Applications Tofacitinib impurity L is an impurity of Tofacitinib (T528000), an …
Formula:
C16H22N6O2
Color and Shape:
Off-White to Pale Orange Solid
Molecular weight:
330.38
Ref: TR-T528015
10mg | 1,091.00 € | |
25mg | 1,954.00 € | |
2500µg | 296.00 € |
Estimated delivery in United States, on Monday 13 May 2024
Tofacitinib impurity L
CAS:1675248-19-7
Please enquire for more information about Tofacitinib impurity L including the price, delivery time and …
Formula:
C16H22N6O2
Purity:
Min. 95%
Molecular weight:
330.38 g/mol
Ref: 3D-ASC24819
1mg | To inquire | |
2mg | To inquire | |
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire |
Estimated delivery in United States, on Friday 14 Jun 2024